medical device investing Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT FDA Clinical Trial
Bold Ventures Intersects 100.7 g/t Gold over 2.95 Meters at Traxxin Main Zone - Expands East Side Potential